RT @VJofBiomedicine: Our recent #interview shows Murtuza Bharmal (@EMDSerono) and Venediktos Kapetanakis (Evidera) summarising their recent…
Our recent #interview shows Murtuza Bharmal (@EMDSerono) and Venediktos Kapetanakis (Evidera) summarising their recent #research paper in PharmacoEconomics @Merck @EMDOncologyUS 🎞 See the full video here: https://t.co/BQy0sIuF8g 📖 And the article here: htt
Our recent #interview shows Murtuza Bharmal (@EMDSerono) and Venediktos Kapetanakis (Evidera) summarising their recent #research paper in PharmacoEconomics @Merck @EMDOncologyUS 🎞 See the full video here: https://t.co/BQy0sId4gI 📖 And the article here: htt
Our recent #interview shows Murtuza Bharmal (@EMDSerono) and Venediktos Kapetanakis (Evidera) summarising their recent #research paper in PharmacoEconomics @Merck @EMDOncologyUS 🎞 See the full video here: https://t.co/BQy0sId4gI 📖 And the article here: htt
RT @evideraglobal: Considering the increasing use of unanchored comparative analyses for novel cancer treatments, the proposed method in th…
RT @evideraglobal: Considering the increasing use of unanchored comparative analyses for novel cancer treatments, the proposed method in th…
Considering the increasing use of unanchored comparative analyses for novel cancer treatments, the proposed method in this recent publication offers a relatively simple means of improving the accuracy of relative benefits of treatments: https://t.co/533Mzf
#HealthEconJA Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer Studies https://t.co/bmMtKa9x7H